Most early ovarian cancers do present with symptoms, reveals a new study published in the journal Obstetrics & Gynecology.1 The researchers carried out a retrospective review of medical records of patients from the Gynecologic Oncology Group (GOG) 157 phase III trial to assess symptoms of early ovarian cancer. All 419 patients evaluated had surgically staged, high-risk early-stage ep ...more
Molnupiravir, a newer oral antiviral drug, has recently acquired emergency use authorization (EUA) in USA, UK and India. A study provided a practical clinical guideline for using molnupiravir in patients with COVID-19.A systematic search of the electronic database of PubMed, MedRxiv and Google Scholar until January 5, 2022, was performed using key MeSH keywords.The following observations were made ...more
We’ll email you the latest developments about the novel coronavirus and eMedinexus top health news stories, daily.
.jpg){kind=small}
.jpg){kind=small}
